US Broker Ratings

Akero Therapeutics, Inc. (AKRO) Investor Outlook: 48% Potential Upside in Biotech Stock

In the dynamic world of biotechnology, Akero Therapeutics, Inc. (NASDAQ: AKRO) stands out as an intriguing prospect for investors, driven by its focus on groundbreaking therapies for serious metabolic diseases...

Qiagen N.V. (QGEN) Stock Analysis: Steady Growth and a 4.16% Potential Upside

Qiagen N.V. (NASDAQ: QGEN), a leading player in the healthcare sector with a focus on diagnostics and research, presents an intriguing opportunity for investors seeking to capitalize on the expanding..

AptarGroup, Inc. (ATR) Stock Analysis: Attractive Growth Potential with 10.83% Upside

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and innovative solutions across the pharmaceutical, beauty, personal care,..

Teleflex Incorporated (TFX) Stock Analysis: An Investor’s Guide to Potential 33.95% Upside

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, specifically in the medical instruments and supplies industry, offers a diverse portfolio that spans vascular access, anesthesia, urology, and..

Ascendis Pharma A/S (ASND) Investor Outlook: Biotech Growth with a 31.85% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a biopharmaceutical company headquartered in Hellerup, Denmark, is making waves in the biotechnology sector with its innovative TransCon-based therapies aimed at addressing unmet medical needs...

Labcorp Holdings Inc. (LH) Stock Analysis: Unveiling 11% Upside Potential and Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a leader in the healthcare diagnostics and research industry, presents a compelling opportunity for investors with its robust growth prospects and strong analyst ratings. Currently..

Integer Holdings Corporation (ITGR): Investor Outlook with a 24% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity for individual investors. With a market capitalization of $4.19..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 28.69% Potential Upside

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services industry, stands out with its innovative cloud-based software solutions tailored for healthcare payments. With a market capitalization of..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 24.72% Potential Upside

Universal Health Services, Inc. (UHS), a prominent player in the healthcare sector, stands out in the medical care facilities industry with a market capitalization of $11.76 billion. Headquartered in King..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating a 63.94% Potential Upside in the Medical Device Sector

Inspire Medical Systems, Inc. (NYSE: INSP), a prominent player in the healthcare sector, is drawing significant attention from the investor community. With a market capitalization of $3.84 billion, the company..

Koninklijke Philips N.V. (PHG) Stock Analysis: Unpacking the 32.20% Potential Upside

Investors with an eye on the healthcare sector may find Koninklijke Philips N.V. (NYSE: PHG) a noteworthy contender, especially given its significant potential upside of 32.20%. As a leading player..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 16% Upside Potential

For investors seeking opportunities in the healthcare sector, Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out with a compelling mix of strong analyst ratings and significant upside potential. As a..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Insights on Healthcare Giant’s Moderate Growth and Investor Ratings

Bausch + Lomb Corporation (BLCO), a prominent player in the healthcare sector, is a company that many investors have their eyes on due to its substantial market presence and a..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook on a Biotechnology Standout with 12 Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is carving a niche in the healthcare industry with its specialized focus on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical entity, Rhythm Pharmaceuticals is making..

Genmab A/S (GMAB) Stock Analysis: 38.73% Potential Upside Fuels Investor Interest

Genmab A/S (NASDAQ: GMAB), a leading biotechnology company headquartered in Copenhagen, Denmark, is capturing investor attention with its promising outlook and a robust 38.73% potential upside. Operating in the dynamic..

ADMA Biologics Inc (ADMA) Stock Analysis: Unveiling a 59% Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, has captured the attention of investors with a compelling potential upside of 59.32%. Specializing in plasma-derived biologics, ADMA..

TG Therapeutics, Inc. (TGTX): Investor Outlook with an 11.10% Upside Potential in Biotechnology

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, continues to capture investor interest with its promising pipeline and strategic focus on B-cell mediated diseases. Headquartered in..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a Potential 24% Upside

For investors seeking exposure to the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents an intriguing opportunity. With a market cap of $14.92 billion, this healthcare titan operates within..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Revenue Growth Soars Amid Promising Drug Pipeline

Cytokinetics, Incorporated (NASDAQ: CYTK), a notable player in the biotechnology sector, has captured investor attention with its robust 89.10% revenue growth and a promising pipeline of muscle-targeted therapies. The company,..

Glaukos Corporation (GKOS) Stock Analysis: Unveiling a 17.97% Potential Upside in the Medical Device Sector

Glaukos Corporation (NYSE: GKOS) is carving out a notable position within the healthcare sector, specifically in the medical devices industry. With a market capitalization of approximately $5.93 billion, this U.S.-based..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds